Israeli Artificial Intelligence Communications Startup Raises $15 Million

Shield team: Company photo by Eric Sultan Israeli startup Shield, which uses an artificial intelligence AI based platform for aiding compliance teams, has closed a $15 million Series A funding round led by Macquarie Capital and OurCrowd with significant participation from Mindset Ventures. This makes Shield the fifth Israeli startup that works with artificial intelligence […]

Continue Reading

Israeli Company SpliSense gets Fda approval for cystic fibrosis treatment

Israeli biopharmaceutical company, SpliSense, announced that the US Food and Medicine Administration (FDA) and the European Medicines Agency have designated the cystic fibrosis treatment technology as an “orphan drug” (EMA). The FDA and EMA designate medicines and biologic technologies as orphan drugs when they are intended to treat rare diseases. “The orphan designations we received […]

Continue Reading